Company Data

Design Therapeutics Inc.

Ticker
DSGN
Current Price
$3.695 -7.86%
Market Cap
$209.8M
Price Target
Refer to Report
Volume
21.2K
52wk Range
$2.6 - $7.77
Advanced Market Data

Overview

Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy